The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Doxepin HCL
Doxepin HCL · DOXEPIN HYDROCHLORIDE 10 mg/1 · Capsule · Oral · Direct_rx
NDC 72189-0574-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Direct RxUnited Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA215076
- TE code
- AB
- Approval date
- Apr 21, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Doxepin HCL (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Direct_rx | DOXEPIN HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Direct_Rx | DOXEPIN HYDROCHLORIDE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Direct_Rx | DOXEPIN HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Doxepin HCL — NDC 72189-0574-30," retrieved September 3, 2026, https://drugdashboards.com/drug/72189057430.
Free to cite with attribution — see how the data is put together.